دورية أكاديمية
Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study.
| العنوان: | Assessing the repercussions of COVID-19 pandemic on symptoms, disease management, and emotional well-being in patients with inflammatory bowel disease: a multi-site survey study. |
|---|---|
| المؤلفون: | El-Dallal M; Division of Hospital Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, USA.; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Saroufim A; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Systrom H; Department of Medicine, Beth Israel Deaconess Medical Center, Boston and Harvard Medical School, MA, USA., Ballou S; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Farhoud A; Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA., Pasam RT; Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA., Gadupudi SS; Division of Gastroenterology, Lahey Hospital and Medical Center, Burlington, MA, USA., Osman K; Department of Medicine, Lahey Hospital and Medical Center, Burlington, MA, USA., Chaudrey K; Division of Gastroenterology, Lahey Hospital and Medical Center, Burlington, MA, USA., Cheifetz A; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Feuerstein JD; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. |
| المصدر: | Scandinavian journal of gastroenterology [Scand J Gastroenterol] 2022 Apr; Vol. 57 (4), pp. 406-414. Date of Electronic Publication: 2021 Dec 11. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 0060105 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1502-7708 (Electronic) Linking ISSN: 00365521 NLM ISO Abbreviation: Scand J Gastroenterol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: London : Informa Healthcare Original Publication: Oslo : Universitetsforlager |
| مواضيع طبية MeSH: | COVID-19*/epidemiology , Inflammatory Bowel Diseases*/complications , Inflammatory Bowel Diseases*/epidemiology , Inflammatory Bowel Diseases*/therapy, Anxiety/epidemiology ; Anxiety/etiology ; Anxiety/psychology ; Chronic Disease ; Disease Management ; Female ; Humans ; Pandemics |
| مستخلص: | Background: Coronavirus disease 2019 (COVID-19) pandemic has created numerous challenges in provision of safe and effective care for patients with Inflammatory Bowel Disease (IBD). In this study, we surveyed patients with IBD to highlight the impact of the pandemic on their IBD symptoms, management, and well-being. Methods: A multi-site survey was administered to patients with IBD. We evaluated patient's symptoms, medications changes, seeking medical attention, eating behaviors, sleep patterns, stress, self-reported anxiety and depression. The survey also measured emotional impact of the pandemic using the validated Pandemic Emotional Impact Scale (PEIS) and resilience using the Brief Resilience Scale (BRS). Logistic, ordinal, and linear regression models were utilized to perform sensitivity analyses. Results: The response rate to the survey was 61%. Of 391 surveyed patients, 21.1% reported worsened gastrointestinal symptoms, 17.5% reported changing biologic medication infusion schedule, 18.7% reported changing medication regimen, 43.6% attended at least one telemedicine visit with their gastroenterologist, 16.5% reported a less healthy diet, 40.5% reported worsening sleep, 63.7% reported more stress, and 65.3% reported feeling more vulnerable than before the pandemic. Women and participants with self-reported anxiety and depression were more likely to have worse symptoms, psychological well-being and daily functioning. Increased PEIS scores and decreased BRS scores were associated with worse outcomes. Conclusions: COVID-19 pandemic has impacted symptoms, disease management and well-being for patient with IBD, more prominently in patients who suffer from anxiety and depression. Utilizing PEIS and BRS scores as screening tools could help better tailor outreach and follow-up to support these patients. |
| فهرسة مساهمة: | Keywords: COVID-19; Crohn’s disease; health; mental health; pandemic; ulcerative colitis |
| تواريخ الأحداث: | Date Created: 20211213 Date Completed: 20220421 Latest Revision: 20220510 |
| رمز التحديث: | 20240628 |
| DOI: | 10.1080/00365521.2021.2013527 |
| PMID: | 34894999 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher | تدمد: | 1502-7708 |
|---|---|
| DOI: | 10.1080/00365521.2021.2013527 |